help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2003-0014
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guan, Y.
Right arrow Articles by Firestone, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guan, Y.
Right arrow Articles by Firestone, G. L.
Molecular Endocrinology 18 (1): 214-227
Copyright © 2004 by The Endocrine Society

Glucocorticoids Control ß-Catenin Protein Expression and Localization through Distinct Pathways that Can Be Uncoupled by Disruption of Signaling Events Required for Tight Junction Formation in Rat Mammary Epithelial Tumor Cells

Yi Guan, Nicola M. Rubenstein, Kim L. Failor, Paul L. Woo and Gary L. Firestone

Department of Molecular and Cell Biology and The Cancer Research Laboratory, University of California at Berkeley, Berkeley, California 94720-3200

Address all correspondence and requests for reprints to: Gary L. Firestone, Department of Molecular and Cell Biology, 591 LSA, University of California at Berkeley, Berkeley, California 94720-3200. E-mail: glfire{at}uclink4.berkeley.edu.

In Con8 rat mammary epithelial tumor cells, the synthetic glucocorticoid dexamethasone stimulates the remodeling of tight junctions and adherens junctions before formation of highly sealed tight junctions. In this study, the expression and localization of key components of the apical junction were examined as potential targets of glucocorticoid signaling. Western blot and RT-PCR demonstrated that dexamethasone up-regulated ß-catenin protein and transcript expression and nearly ablated ß-catenin phosphorylation under conditions that led to a significant increase in monolayer transepithelial resistance. Indirect immunofluorescence revealed that dexamethasone treatment also caused ß-catenin to localize predominantly at the cell membrane rather than the nucleus. The glucocorticoid regulation of ß-catenin expression and localization was not a consequence of dexamethasone inhibition of cell growth, because both responses were unaltered in the presence of hydroxyurea. The steroid induction of ß-catenin expression and localization can be uncoupled by altering the function of signaling pathways needed for tight junction formation. Expression of dominant-negative RasN17 abolished dexamethasone up-regulation of ß-catenin protein expression without affecting its localization at the membrane. In contrast, exogenous treatment or constitutive production of TGF{alpha} abolished the dexamethasone-induced alteration of ß-catenin localization without affecting the dexamethasone stimulation of ß-catenin expression. Taken together, our results demonstrate that glucocorticoids control ß-catenin at two distinct levels of cellular regulation that differ in their cell signaling requirements for the glucocorticoid regulation of mammary epithelial junctional dynamics.

NURSA Molecule Pages Link:

Ligands:   Dexamethasone  |  RU486



This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Gratchev, J. Kzhyshkowska, S. Kannookadan, M. Ochsenreiter, A. Popova, X. Yu, S. Mamidi, E. Stonehouse-Usselmann, I. Muller-Molinet, L. Gooi, et al.
Activation of a TGF-{beta}-Specific Multistep Gene Expression Program in Mature Macrophages Requires Glucocorticoid-Mediated Surface Expression of TGF-{beta} Receptor II
J. Immunol., May 15, 2008; 180(10): 6553 - 6565.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. L. Failor, Y. Desyatnikov, L. A. Finger, and G. L. Firestone
Glucocorticoid-Induced Degradation of Glycogen Synthase Kinase-3 Protein Is Triggered by Serum- and Glucocorticoid-Induced Protein Kinase and Akt Signaling and Controls {beta}-Catenin Dynamics and Tight Junction Formation in Mammary Epithelial Tumor Cells
Mol. Endocrinol., October 1, 2007; 21(10): 2403 - 2415.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Takayama, I. Rogatsky, L. E. Schwarcz, and B. D. Darimont
The Glucocorticoid Receptor Represses Cyclin D1 by Targeting the Tcf-beta-Catenin Complex
J. Biol. Chem., June 30, 2006; 281(26): 17856 - 17863.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson
Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know?
Endocr. Rev., December 1, 2005; 26(7): 898 - 915.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Fonte, J. Grenier, A. Trousson, A. Chauchereau, O. Lahuna, E.-E. Baulieu, M. Schumacher, and C. Massaad
Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells
PNAS, October 4, 2005; 102(40): 14260 - 14265.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K.-J. Kim, Z. Borok, C. Ehrhardt, B. C. Willis, C.-M. Lehr, and E. D. Crandall
Estimation of paracellular conductance of primary rat alveolar epithelial cell monolayers
J Appl Physiol, January 1, 2005; 98(1): 138 - 143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society